Flash FinanceUS
Pre-market S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI filing briefs · archive

8-K filings in December 2025, explained

619 material Form 8-K filings that 507 companies we cover made with the SEC in December 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).

Clear

1 of 619 briefs matches

newest first · times in ET
PMCBPharmaCyte Biotech, Inc. Dec 5, 5:00 PM ET

PharmaCyte Biotech receives Nasdaq bid price deficiency notice; 180 days to regain compliance

Negative legal/regulatory Written later 3.01

PharmaCyte Biotech received a Nasdaq notice on December 1, 2025, saying its common stock no longer meets the $1.00 minimum bid price for continued listing on the Nasdaq Capital Market. The notice has no immediate effect on listing or trading, and the company has until June 1, 2026 to regain compliance, which matters to shareholders because continued failure could lead to delisting.

  • Nasdaq notice dated December 1, 2025 cites failure to meet the $1.00 minimum bid price under Listing Rule 5550(a)(2)
  • Compliance Date is June 1, 2026, a 180-day period; regaining compliance requires at least $1.00 closing bid for 10 consecutive business days
  • Stock continues to trade under PMCB; the company may seek a second 180-day period or consider a reverse stock split subject to stockholder approval
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.

Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.